Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? - Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year.

Related Keywords

Chicago ,Illinois ,United States ,Bruce Cozaddhighlighted ,Epidiolex Epidyolex ,Hikma Pharmaceuticals ,Jazz Pharmaceuticals ,Benzinga Cannabis Capital Conference ,